Role of superoxide in catalase-peroxidase-mediated isoniazid action against mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 709-711

  Wang, Jian Ying ^a   Burger, Richard M ^a,b   Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b Redox Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; ISONIAZID; MYCOLIC ACID; PEROXIDASE; PLASMID VECTOR; PLUMBAGIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; CONTROLLED STUDY; DRUG ACTIVATION; DRUG MECHANISM; DRUG OXIDATION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; INTRACELLULAR KILLING; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031942624     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.709     Document Type: Article

References (26)

1. Banerjee, A., E. Dubnau, A. Quémard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs. 1994. inhA, a gene encoding a target for isoniazid and ethionamide resistance in Mycobacterium tuberculosis. Science 263:227-230.
2. 1a.Barry, C. Personal communication.
3. Deretic, V., E. Pagan-Ramos, Y. Zhang, S. Dhandayuthapani, and L. Via. 1996. The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid. Nat. Biotechnol. 14:1557-1561.
4. Dessen, A., A. Quémard, J. Blanchard, W. Jacobs, and J. C. Sacchettini. 1995. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267:1638-1641.
5. Dhandayuthapani, S., Y. Zhang, M. H. Mudd, and V. Deretic. 1996. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J. Bacteriol. 178:3641-3649.
6. DiGuiseppe, J., and I. Fridovich. 1982. Oxygen toxicity in Streptococcus sanguis: the relative importance of superoxide and hydroxyl radicals. J. Biol. Chem. 257:4046-4051.
7. Escuyer, V., N. Haddod, C. Frehel, and P. Berche. 1996. Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium. Microb. Pathog. 20:41-55.
8. Heym, B., P. Alzari, N. Honore, and S. Cole. 1995. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol. Microbiol. 15:235-245.
9. Heym, B., and S. T. Cole. 1992. Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum. Res. Microbiol. 143:721-730.
10. Ito, K., K. Yamamoto, and S. Kawanishi. 1992. Manganese-mediated oxidative damage of cellular and isolated DNA by isoniazid and related hydrazines: non-Fenton-type hydroxyl radical formation. Biochemistry 31:11606-11613.
11. Johnsson, K., D. King, and P. Schultz. 1995. Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J. Am. Chem. Soc. 117:5009-5010.
12. Johnsson, K., and P. Schultz. 1994. Mechanistic studies of the oxidation of isoniazid by the catalase peroxidase from Mycobacterium tuberculosis. J. Am. Chem. Soc. 116:7425-7426.
13. Kapoor, V. K. 1989. Clofazimine. Anal. Profiles Drug Subst. 18:91-120.
14. Karat, A. B., A. Jeevaratnam, S. Karat, and P. S. Rao. 1971. Controlled clinical trial of clofazimine in untreated lepromatous leprosy. Br. Med. J. 4:514-516.
15. Magliozzo, R. S., and J. A. Marcinkeviciene. 1996. Evidence for isoniazid oxidation to oxyferrous mycobacterial catalase-peroxidase. J. Am. Chem. Soc. 118:11303-11304.
16. Mdluli, K., D. Sherman, M. Hickey, B. Kreiswirth, S. Morris, C. K. Stover, and C. E. Barry. 1996. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J. Infect. Dis. 174:1085-1090.
17. Quémard, A., C. Lacave, and G. Lanéelle. 1991. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob. Agents Chemother. 35:1035-1039.
18. Reddy, V. M., G. Nadadhur, D. Daneluzzi, J. F. O'Sullivan, and P. R. J. Gangadharam. 1996. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Antimicrob. Agents Chemother. 40:633-636.
19. Rosner, J. L., and G. Storz. 1994. Effects of peroxides on susceptibilities of Escherichia coli and Mycobacterium smegmatis to isoniazid. Antimicrob. Agents Chemother. 38:1829-1833.
20. Shoeb, H. A., B. U. Bowman, Jr., A. C. Ottolenghi, and A. J. Merola. 1985. Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid. Antimicrob. Agents Chemother. 27:408-412.
21. Shoeb, H. A., B. U. Bowman, Jr., A. C. Ottolenghi, and A. J. Merola. 1985. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 27:404-407.
22. Takayama, K., L. Wang, and H. L. David. 1972. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2:29-35.
23. Warek, U., and J. O. Falkinham III. 1996. Action of clofazimine on the Mycobacterium avium complex. Res. Microbiol. 147:43-48.
24. Zabinski, R. F., and J. S. Blanchard. 1997. The requirement for manganese and oxygen in the isoniazid-dependent inactivation of Mycobacterium tuberculosis enoyl reductase. J. Am. Chem. Soc. 119:2331-2332.
25. Zhang, Y., S. Dhandayuthapani, and V. Deretic. 1996. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc. Natl. Acad. Sci. USA 93:13212-13216.
26. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.